摘要
The liver is the most common metastatic site for patients with colorectal cancer(CRC),and over 50%of cases show liver metastases.Furthermore,approximately 15-25%of CRC patients present with liver metastases at the time of diagnosis,and liver metastases are the primary cause of death in CRC patients.Although they lacked results from large-sample,prospective clinical trials,retrospective studies in the 1990s showed that hepatectomy is associated with long-term survival in patients with CRC liver metastases(CRLM),who benefited from a 5-year survival rate of more than 50%(1,2).However,the 5-year survival rate of inoperable patients is less than 10%.
基金
This work was supported by Beijing CSCO Clinical Oncology Research Foundation CSCO-Linghang Project(Y-2019AZMS-0082)and the Capital’s Funds for Health Improvement and Research(2018-1-4021).
